INVO Fertility signs equity purchase agreement for up to $15 million stock sales to Alumni Capital

• Invo Fertility entered an any-market purchase agreement with Alumni Capital for up to $15 million of common stock, expandable to $50 million.
• Sales are at the company’s option, subject to an effective Form S-1 registration statement and final prospectus filing.
• Pricing is set at a discount to recent trading levels: 94% of the lowest 5-day VWAP, 97% of the prior-day low, or 85% of the lowest 5-day low.
• Proceeds are earmarked for expansion, with a focus on acquiring established, profitable fertility clinics, alongside general corporate purposes.
• Stockholders voted July 23, 2026 to permit issuances above Nasdaq’s 19.99% exchange cap under the agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034616), on July 24, 2026, and is solely responsible for the information contained therein.